Study of prognosis in people with paroxysmal kinesigenic choreoathetosis
Part of Brain & nervous system clinical trials.
This study looks at how paroxysmal kinesigenic choreoathetosis (PKC) typically progresses over time in people in Korea. It may help doctors better predict outcomes and plan care. You may be asked about your diagnosis and results from brain and brain-wave tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a confirmed diagnosis of paroxysmal kinesigenic choreoathetosis (PKC).
- You choose to join the study and understand what participation involves.
- Your brain scans (if done) do not show any brain lesions (abnormal spots).
- Your brain health tests do not suggest a brain cause for any neurologic deficits (new/worsening nerve-related symptoms).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people with a specific genetic heart condition (PKP2-related arrhythmogenic cardiomyopathy) who already have an ICD. It does not test a new treatment but instead follows participants over time to learn more about the condition.
This study follows people with a confirmed PKP2 genetic mutation and arrhythmogenic cardiomyopathy (ACM) to understand how their condition changes over time. It may help doctors learn more about the disease and plan future treatments.
This study uses brain scans to understand movement problems in people with a specific genetic change (PRRT2) that causes sudden, brief episodes of uncontrolled movements. It may help researchers find better ways to treat this condition.
This study looks at how plakophilin 2 (PKP2)-related arrhythmogenic right ventricular cardiomyopathy (ARVC) progresses over time. You'll give blood samples to check for antibodies to a virus used in gene therapy, and help doctors understand the disease better.
This study looks for biological “markers” (measurable signs in the body) in people with inherited movement disorders, and in some related family members or healthy volunteers. It may help researchers better understand these conditions, especially for future diagnosis and care.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
Hear when a new Paroxysmal Kinesigenic Choreoathetosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.